BRIEF published on 02/02/2026 at 15:41, 5 hours 1 minute ago CHEPLAPHARM's Successful €950m Bond Issuance Refinancing Bond Issuance Financial Strategy Investor Demand CHEPLAPHARM
PRESS RELEASE published on 02/02/2026 at 15:36, 5 hours 6 minutes ago Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed CHEPLAPHARM successfully refinances with new 6.750% bond oversubscribed multiple times, enhancing financial flexibility and maturity profile Refinancing Oversubscribed Financial Flexibility CHEPLAPHARM 6.750% Bond
BRIEF published on 08/27/2025 at 13:34, 5 months 6 days ago CHEPLAPHARM Reports Stable Growth in the First Half of 2025 Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
PRESS RELEASE published on 08/27/2025 at 13:29, 5 months 6 days ago CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024 Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG
BRIEF published on 06/26/2025 at 10:36, 7 months 6 days ago CHEPLAPHARM's €750M Bond Sees High Demand and Attractive Pricing Pharmaceuticals Investor Confidence Financial Flexibility Bonds CHEPLAPHARM
PRESS RELEASE published on 06/26/2025 at 10:31, 7 months 6 days ago High Demand and Attractive Pricing: CHEPLAPHARM's New 7.125% Bond Multiple Times Oversubscribed CHEPLAPHARM successfully places €750m senior secured notes at 7.125% interest rate, enhancing financial flexibility and extending maturity profile, oversubscribed transaction Senior Secured Notes Oversubscribed Financial Flexibility CHEPLAPHARM 7.125%
BRIEF published on 06/02/2025 at 10:34, 8 months ago Sandra Schröder Joins CHEPLAPHARM as VP Scientific Pharmaceutical Regulatory Affairs Quality Management CHEPLAPHARM Sandra Schröder
PRESS RELEASE published on 06/02/2025 at 10:29, 8 months ago Sandra Schröder joins CHEPLAPHARM’S Management Team as VP Scientific Sandra Schröder appointed as VP Scientific at CHEPLAPHARM, responsible for scientific areas globally. Brings 25 years of experience from F. Hoffmann-La Roche AG Pharmaceutical Industry Management CHEPLAPHARM Sandra Schröder VP Scientific
BRIEF published on 01/02/2025 at 09:19, 1 year 1 month ago CHEPLAPHARM Appoints Tamás Szóga as VP Commercial Management Expansion CHEPLAPHARM Tamás Szóga VP Commercial Pharmaceutical Strategy
PRESS RELEASE published on 01/02/2025 at 09:14, 1 year 1 month ago CHEPLAPHARM expands Management with Tamás Szóga as VP Commercial CHEPLAPHARM expands management team by appointing Tamás Szóga as VP Commercial, responsible for strategic planning and development of Global Sales division Global Sales Strategic Planning CHEPLAPHARM Tamás Szóga VP Commercial
Published on 02/02/2026 at 15:00, 5 hours 42 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago Unusual Machines Promotes Drew Camden to President
Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet
Published on 02/02/2026 at 14:30, 6 hours 12 minutes ago NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Published on 02/02/2026 at 14:00, 6 hours 42 minutes ago Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Published on 02/02/2026 at 20:00, 42 minutes ago CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 45 minutes ago US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 59 minutes ago EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 1 hour 37 minutes ago Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 18:59, 1 hour 43 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Oil and Gas Reserves increase by 46% – NPV of USD 542 million at USD 60 WTI oil price
Published on 02/02/2026 at 18:23, 2 hours 19 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 2 hours 42 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 17:35, 3 hours 7 minutes ago Disclosure of transactions in own shares from January 26 to January 30, 2026
Published on 02/02/2026 at 17:22, 3 hours 20 minutes ago Statement of transactions in own shares from January 26, 2026 to January 30, 2026
